Saliwell Ltd.

Saliwell Ltd. is a medical device company that develops non-pharmacological, high-tech solutions for xerostomia, commonly known as dry mouth. The company's core product, SaliPen, is an FDA-cleared, removable intraoral device that uses gentle electrostimulation to activate salivary glands and promote natural saliva production. By delivering targeted electrical impulses to the lingual nerve, the device provides a drug-free alternative to traditional pharmacological treatments, which often carry undesirable side effects. The technology is designed to be used for short durations throughout the day to help patients manage symptoms, improve oral comfort, and facilitate speaking and swallowing.

This approach matters to patients suffering from chronic dry mouth, including those with conditions like Sjögren’s syndrome or those experiencing salivary gland dysfunction due to medication use. Saliwell’s solution addresses the significant daily challenges and health risks associated with insufficient saliva, such as increased dental decay and oral discomfort. The efficacy of the company's electrostimulation technology has been supported by published clinical research, including randomized sham-controlled studies demonstrating meaningful improvements in salivary function and patient-reported symptoms. Led by founders Dr. Andy Wolff, a specialist in oral medicine, and Ben Z. Beiski, an engineer, Saliwell continues to advance its technology through ongoing research and development to improve the quality of life for xerostomia patients worldwide.